Synthesized compounds were evaluated for their in vitro anticancer activity against various human cancer cell lines, including breast and prostate.
[Bioorganic Chemistry]
6445218
{6445218:Y9WP36VB}
apa
50
1
165281
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-2abfbbd1f92191b3d9d3274936a17f76%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22Y9WP36VB%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Parmar%20et%20al.%22%2C%22parsedDate%22%3A%222021-10-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EParmar%2C%20D.%20R.%2C%20Soni%2C%20J.%20Y.%2C%20Guduru%2C%20R.%2C%20Rayani%2C%20R.%20H.%2C%20Kusurkar%2C%20R.%20V.%2C%20Vala%2C%20A.%20G.%2C%20Talukdar%2C%20S.%20N.%2C%20Eissa%2C%20I.%20H.%2C%20Metwaly%2C%20A.%20M.%2C%20Khalil%2C%20A.%2C%20Zunjar%2C%20V.%2C%20%26amp%3B%20Battula%2C%20S.%20%282021%29.%20Discovery%20of%20new%20anticancer%20thiourea-azetidine%20hybrids%3A%20design%2C%20synthesis%2C%20in%20vitro%20antiproliferative%2C%20SAR%2C%20in%20silico%20molecular%20docking%20against%20VEGFR-2%2C%20ADMET%2C%20toxicity%2C%20and%20DFT%20studies.%20%3Ci%3EBioorganic%20Chemistry%3C%5C%2Fi%3E%2C%20%3Ci%3E115%3C%5C%2Fi%3E%2C%20105206.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.bioorg.2021.105206%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.bioorg.2021.105206%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3DY9WP36VB%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Discovery%20of%20new%20anticancer%20thiourea-azetidine%20hybrids%3A%20design%2C%20synthesis%2C%20in%20vitro%20antiproliferative%2C%20SAR%2C%20in%20silico%20molecular%20docking%20against%20VEGFR-2%2C%20ADMET%2C%20toxicity%2C%20and%20DFT%20studies%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deepa%20R.%22%2C%22lastName%22%3A%22Parmar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jigar%20Y.%22%2C%22lastName%22%3A%22Soni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ramakrishna%22%2C%22lastName%22%3A%22Guduru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rahul%20H.%22%2C%22lastName%22%3A%22Rayani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rakesh%20V.%22%2C%22lastName%22%3A%22Kusurkar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anand%20G.%22%2C%22lastName%22%3A%22Vala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sahista%20N.%22%2C%22lastName%22%3A%22Talukdar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ibrahim%20H.%22%2C%22lastName%22%3A%22Eissa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahmed%20M.%22%2C%22lastName%22%3A%22Metwaly%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahmed%22%2C%22lastName%22%3A%22Khalil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vishwanath%22%2C%22lastName%22%3A%22Zunjar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Satyanarayana%22%2C%22lastName%22%3A%22Battula%22%7D%5D%2C%22abstractNote%22%3A%22With%20the%20aim%20to%20discover%20potent%20and%20novel%20antitumor%20agents%2C%20a%20series%20of%20thiourea%20compounds%20bearing%203-%284-methoxyphenyl%29azetidine%20moiety%20were%20designed%20according%20to%20the%20essential%20pharmacophoric%20features%20of%20the%20reported%20VEGFR-2%20inhibitors%20and%20synthesized.%20All%20the%20synthesized%20compounds%20were%20evaluated%20for%20their%20in%20vitro%20anticancer%20activity%20against%20various%20human%20cancer%20cell%20lines%20%28lung%20%28A549%29%2C%20prostate%20%28PC3%29%2C%20breast%20%28MCF-7%29%2C%20liver%20%28HepG2%29%2C%20colon%20%28HCT-116%29%2C%20ovarian%20%28SKOV-3%29%2C%20skin%20%28A431%29%2C%20brain%20%28U251%29%20and%20kidney%20%28786-O%29%29.%203-%284-Methoxy-3-%282-methoxypyridin-4-yl%29phenyl%29-N-%284-methoxyphenyl%29azetidine-1-carbothioamide%20%283B%29%20was%20found%20to%20be%20most%20potent%20member%20against%20PC3%2C%20U251%2C%20A431%2C%20and%20786-O%20cancer%20cell%20lines%20with%20EC50%20values%200.25%2C%200.6%2C%200.03%2C%20and%200.03%5Cu00a0%5Cu00b5M%2C%20respectively%20and%20showed%20more%20potency%20than%20Doxorubicin%20in%20PC3%2C%20A431%2C%20and%20786-O%20cell%20lines.%20Compounds%201B%20to%207B%20showed%20EC50%20values%20ranging%20from%200.03%20to%2012.55%5Cu00a0%5Cu00b5M%20in%20A431%20cell%20line.%20Compound%203-%284-methoxy-3-%28pyridin-4-yl%29phenyl%29-N-%284-methoxyphenyl%29azetidine-1-carbothioamide%20%281B%29%20was%20found%20to%20be%20highly%20efficient%20in%20A431%20and%20786-O%20cell%20line%20with%20EC50%20values%20of%200.77%20and%200.73%5Cu00a0%5Cu00b5M%20respectively.%20All%20the%20compounds%20exhibited%20good%20to%20moderate%20cytotoxic%20activity.%20The%20pharmacophoric%20features%20and%20molecular%20docking%20studies%20confirmed%20the%20potentialities%20of%20compounds%201B%2C%202B%2C%203B%20and%205B%20to%20be%20VEGFR-2%20inhibitors.%20Moreover%2C%20in%20silico%20ADMET%20prediction%20indicated%20that%20most%20of%20the%20synthesized%20compounds%20have%20drug-like%20properties%2C%20possess%20low%20adverse%20effects%20and%20toxicity.%20In%20addition%2C%20the%20DFT%20studies%20for%20the%20most%20active%20compounds%20%281B%20and%203B%29%20were%20carried%20out.%20In%20the%20end%2C%20our%20studies%20revealed%20that%20the%20compounds%201B%20and%203B%20represent%20promising%20anticancer%20potentialities%20through%20their%20VEGFR-2%20inhibition.%22%2C%22date%22%3A%22October%201%2C%202021%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.bioorg.2021.105206%22%2C%22ISSN%22%3A%220045-2068%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0045206821005836%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-08-03T20%3A28%3A04Z%22%7D%7D%5D%7D
Parmar, D. R., Soni, J. Y., Guduru, R., Rayani, R. H., Kusurkar, R. V., Vala, A. G., Talukdar, S. N., Eissa, I. H., Metwaly, A. M., Khalil, A., Zunjar, V., & Battula, S. (2021). Discovery of new anticancer thiourea-azetidine hybrids: design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies. Bioorganic Chemistry, 115, 105206. https://doi.org/10.1016/j.bioorg.2021.105206 Cite
